<TABLE>
<TR><TD COLSPAN=5><a name="description"></a>&nbsp;<p><p align='CENTER'><strong> 8.A.24 The Ezrin/Radixin/Moesin-binding Phosphoprotein 50 (EBP50) Family</strong></p>
<p><span style='font-family: Times;'> EBP50 is a Na<sup>+</sup></span>/H<sup>+</sup> exchange regulatory cofactor, called NHE-RF or NHERF-1, of 358 aas (Slc9 isoform A3, regulatory factor 3).  It is an adaptor protein that organizes a number of cell receptors and channels (<span id='ref3261.16129695' class='cite'>Li <em>et al</em>., 2005</span>).  It contains two PDZ domains that bind to the cytoplasmic domains of a number of membrane channels, carriers and receptors to coordinate the assembly and trafficking of these transmembrane proteins. Most target
proteins harboring a C-terminus recognition motif bind more-or-less equivalently to either of the PDZ
domains, which contain identical core-binding motifs. However some substrates such as the type II
sodium-dependent phosphate co-transporter (NPT2A), uniquely bind only one PDZ domain (<span id='ref34544160.26070212' class='cite'>Mamonova <em>et al.</em> 2015</span>).&nbsp;</p>
<p>NHERF1 (TC# 8.A.24.1.1 and NHERF2 (E3KARP) (TC# 8.A.24.1.2) are homologous adapter proteins that play roles in membrane protein targeting, trafficking, and sorting (<span id='ref34550474.15721789' class='cite'>Park <em>et al.</em> 2005</span>). Both NHERF1 and 2 interact with the <span style='font-family: Times;'>Na<sup>+</sup></span>/H<sup>+</sup> exchanger, NHE3, through their C-terminally extended second PDZ domain. The last 30 amino acids of these PDZ domain proteins interact with ezrin (TC# 8.A.25.1.1). Both soluble NHERF proteins have been purified (<span id='ref34550474.15721789' class='cite'>Park <em>et al.</em> 2005</span>).</p>
<p>The carboxyl terminus of NHERF interacts with the FERM domain (a domain shared by protein <span style='text-decoration: underline;'>4</span>.1, <span style='text-decoration: underline;'>e</span>zrin, <span style='text-decoration: underline;'>radixin</span>, and <span style='text-decoration: underline;'>moesin</span>) of a family of actin-binding proteins called the ezrin-radixin-moesin family (TC #8.A.25). NHERF enhances the channel activities of cystic fibrosis transmembrane conductance regulator (CFTR) (TC #3.A.1.202.1). Binding of the FERM domain of ezrin to NHERF regulates the cooperative binding of NHERF to bring two cytoplasmic tails of CFTR into spatial proximity to each other. Ezrin binding activates the second PDZ domain of NHERF to interact with the cytoplasmic tails of CFTR (C-CFTR), so as to form a specific 2:1:1 (C-CFTR)<sub>2</sub>&middot;NHERF&middot;ezrin ternary complex. EPP50 is required both for plasma membrane localization and for maximal activation of CFTR (<span id='ref4546.17947234' class='cite'>Broere <em>et al</em>., 2007</span>). Without ezrin binding, the cytoplasmic tail of CFTR only interacts strongly with the first amino-terminal PDZ domain to form a 1:1 C-CFTR&middot;NHERF complex. Because of the concentrated distribution of ezrin and NHERF in the apical membrane regions of epithelial cells and the diverse binding partners for the NHERF PDZ domains, the regulation of NHERF by ezrin may be employed as a general mechanism to assemble channels and receptors in the membrane cytoskeleton (<span id='ref3261.16129695' class='cite'>Li <em>et al</em>., 2005</span>).</p>
<p>The sodium-dependent glutamate transporter, glutamate transporter subtype 1 (GLT-1) is one of the main glutamate transporters in the brain. GLT-1 contains a COOH-terminal sequence similar to one in an isoform of Slo1 K<sup>+</sup>&nbsp;channel protein previously shown to bind MAGI-1 (membrane-associated guanylate kinase with inverted orientation protein-1), a member of the EBP50 family (TC#8.A.24) (<span id='ref8804.21426345' class='cite'>Zou <em>et al.</em>, 2011</span>). MAGI-1 is a scaffold protein which allows the formation of complexes between certain transmembrane proteins, actin-binding proteins, and other regulatory proteins. MAGI-1 is a binding partner of GLT-1. The interaction between MAGI-1 and GLT-1 was confirmed by co-immunoprecipitation. Immunofluorescence of MAGI-1 and GLT-1 demonstrated that the distribution of MAGI-1 and GLT-1 overlapped in astrocytes. Co-expression of MAGI-1 with GLT-1 in C6 Glioma cells resulted in a significant reduction in the surface expression of GLT-1, as assessed by cell-surface biotinylation. On the other hand, partial knockdown of endogenous MAGI-1 expression by small interfering RNA in differentiated cultured astrocytes increased glutamate uptake and the surface expression of endogenous GLT-1. Knockdown of MAGI-1 increased dihydrokainate-sensitive, Na<sup>+</sup>-dependent glutamate uptake, indicating that MAGI-1 regulates GLT-1-mediated glutamate uptake. These data suggest that MAGI-1 regulates surface expression of GLT-1 and the level of glutamate in the hippocampus (<span id='ref8804.21426345' class='cite'>Zou <em>et al.</em>, 2011</span>).&nbsp;</p>
<p>Many protein of TC families 8.A.22 and 8.A.24 and others contain PDZ, SH3 and kinase domains involved in signal transduction, often interacting with receptors and transporters. Therefore, these two families share about 400 aas in common.&nbsp; PDZ proteins of the NHERF
 family act to stabilize and organize membrane targeting of multiple 
transmembrane proteins, including many clinically relevant drug 
transporters. These PDZ proteins are normally abundant at apical 
membranes, where they tether membrane-delimited transporters. NHERF 
expression is high at the apical membrane in polarized 
tissue such as intestinal, hepatic, and renal epithelia. 
NHERF proteins are determinants of drug transporter function in addition to
 their role in controlling membrane abundance and localization. They may have clinically 
significant roles in pharmacokinetics and pharmacodynamics of several 
pharmacologically active compounds and may affect drug action in cancer 
and chronic kidney disease. For these reasons, NHERF proteins represent a
 novel class of post-translational mediators of drug transport and novel
 targets for new drug development (<span id='ref34544181.26092975' class='cite'>Walsh <em>et al.</em> 2015</span>).</p><BR></TD></TR><TR><TD COLSPAN=5><a name="references"></a>&nbsp;<p><B>References:</B><P></TD></TR><TR><TD COLSPAN=5>Addi, C., A. Presle, S. Frémont, F. Cuvelier, M. Rocancourt, F. Milin, S. Schmutz, J. Chamot-Rooke, T. Douché, M. Duchateau, Q. Giai Gianetto, A. Salles, H. Ménager, M. Matondo, P. Zimmermann, N. Gupta-Rossi, and A. Echard. (2020).  The Flemmingsome reveals an ESCRT-to-membrane coupling via ALIX/syntenin/syndecan-4 required for completion of cytokinesis.  Nat Commun 11: 1941.<BR><HR></TD></TR><TR><TD COLSPAN=5>Bannert, K., P. Berlin, J. Reiner, H. Lemcke, R. David, R. Engelmann, and G. Lamprecht. (2020).  SNX27 regulates DRA activity and mediates its direct recycling by PDZ-interaction in early endosomes at the apical pole of Caco2 cells.  Am. J. Physiol. Gastrointest Liver Physiol 318: G854-G869.<BR><HR></TD></TR><TR><TD COLSPAN=5>Bhattacharya, S., C.B. Stanley, W.T. Heller, P.A. Friedman, and Z. Bu. (2019).  Dynamic structure of the full-length scaffolding protein NHERF1 influences signaling complex assembly.  J. Biol. Chem. [Epub:  Ahead of Print]<BR><HR></TD></TR><TR><TD COLSPAN=5>Borisovska, M. (2018).  Syntaxins on granules promote docking of granules via interactions with munc18.  Sci Rep 8: 193.<BR><HR></TD></TR><TR><TD COLSPAN=5>Broere, N., J. Hillesheim, B. Tuo, H. Jorna, A.B. Houtsmuller, S. Shenolikar, E.J. Weinman, M. Donowitz, U. Seidler, H.R. de Jonge, and B.M. Hogema. (2007). Cystic Fibrosis Transmembrane Conductance Regulator Activation Is Reduced in the Small Intestine of Na<SUP>+</SUP>/H<SUP>+</SUP> Exchanger 3 Regulatory Factor 1 (NHERF-1)- but Not NHERF-2-deficient Mice. J. Biol. Chem. 282: 37575-37584. <BR><HR></TD></TR><TR><TD COLSPAN=5>Brückner, K., J. Pablo Labrador, P. Scheiffele, A. Herb, P.H. Seeburg, and R. Klein. (1999).  EphrinB ligands recruit GRIP family PDZ adaptor proteins into raft membrane microdomains.  Neuron. 22: 511-524.<BR><HR></TD></TR><TR><TD COLSPAN=5>Cheng, J., B.D. Moyer, M. Milewski, J. Loffing, M. Ikeda, J.E. Mickle, G.R. Cutting, M. Li, B.A. Stanton, and W.B. Guggino. (2002).  A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression.  J. Biol. Chem. 277: 3520-3529.<BR><HR></TD></TR><TR><TD COLSPAN=5>Cheng, J., H. Wang, and W.B. Guggino. (2004).  Modulation of mature cystic fibrosis transmembrane regulator protein by the PDZ domain protein CAL.  J. Biol. Chem. 279: 1892-1898.<BR><HR></TD></TR><TR><TD COLSPAN=5>El-Haou, S., E. Balse, N. Neyroud, G. Dilanian, B. Gavillet, H. Abriel, A. Coulombe, A. Jeromin, and S.N. Hatem. (2009).  Kv4 potassium channels form a tripartite complex with the anchoring protein SAP97 and CaMKII in cardiac myocytes.  Circ Res 104: 758-769.<BR><HR></TD></TR><TR><TD COLSPAN=5>Engel, M., P. Snikeris, N. Matosin, K.A. Newell, X.F. Huang, and E. Frank. (2016).  mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.  Psychopharmacology (Berl) 233: 1349-1359.<BR><HR></TD></TR><TR><TD COLSPAN=5>Fanning, A.S., B.J. Jameson, L.A. Jesaitis, and J.M. Anderson. (1998).  The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton.  J. Biol. Chem. 273: 29745-29753.<BR><HR></TD></TR><TR><TD COLSPAN=5>Furuse, M., M. Itoh, T. Hirase, A. Nagafuchi, S. Yonemura, S. Tsukita, and S. Tsukita. (1994).  Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions.  J. Cell Biol. 127: 1617-1626.<BR><HR></TD></TR><TR><TD COLSPAN=5>Giepmans, B.N. (2006).  Role of connexin43-interacting proteins at gap junctions.  Adv Cardiol 42: 41-56.<BR><HR></TD></TR><TR><TD COLSPAN=5>He, J., M. Bellini, J. Xu, A.M. Castleberry, and R.A. Hall. (2004).  Interaction with cystic fibrosis transmembrane conductance regulator-associated ligand (CAL) inhibits beta1-adrenergic receptor surface expression.  J. Biol. Chem. 279: 50190-50196.<BR><HR></TD></TR><TR><TD COLSPAN=5>Jeyifous, O., E.I. Lin, X. Chen, S.E. Antinone, R. Mastro, R. Drisdel, T.S. Reese, and W.N. Green. (2016).  Palmitoylation regulates glutamate receptor distributions in postsynaptic densities through control of PSD95 conformation and orientation.  Proc. Natl. Acad. Sci. USA 113: E8482-E8491.<BR><HR></TD></TR><TR><TD COLSPAN=5>Jurkiewicz, D., K. Michalec, K. Skowronek, and K.A. Nałęcz. (2017).  Tight junction protein ZO-1 controls organic cation/carnitine transporter OCTN2 (SLC22A5) in a protein kinase C-dependent way.  Biochim. Biophys. Acta. 1864: 797-805.<BR><HR></TD></TR><TR><TD COLSPAN=5>Li, J., Z. Dai, D. Jana, D.J. Callaway, and Z. Bu.  (2005).  Ezrin controls the macromolecular complexes formed between an adapter protein Na<size=2><sup>+</sup></font>/H<size=2><sup>+</sup></font> exchanger regulatory factor and the cystic fibrosis transmembrane conductance regulator.  J Biol Chem. 280: 37634-37643. <BR><HR></TD></TR><TR><TD COLSPAN=5>Mamonova, T., Q. Zhang, J.A. Khajeh, Z. Bu, A. Bisello, and P.A. Friedman. (2015).  Canonical and Noncanonical Sites Determine NPT2A Binding Selectivity to NHERF1 PDZ1.  PLoS One 10: e0129554.<BR><HR></TD></TR><TR><TD COLSPAN=5>Mitsou, I., H.A.B. Multhaupt, and J.R. Couchman. (2017).  Proteoglycans, ion channels and cell-matrix adhesion.  Biochem. J. 474: 1965-1979.<BR><HR></TD></TR><TR><TD COLSPAN=5>Nicolodi, M. and F. Sicuteri. (1996).  Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pathogenesis and therapy.  Adv Exp Med Biol 398: 373-379.<BR><HR></TD></TR><TR><TD COLSPAN=5>Niu, W., X. Rong, Q. Zhao, X. Liu, L. Xu, S. Li, and X. Li. (2023).  [Wine-processed  enhances efficacy of aumolertinib against EGFRmutant non-small cell lung cancer xenografts in nude mouse brain].  Nan Fang Yi Ke Da Xue Xue Bao 43: 375-382.<BR><HR></TD></TR><TR><TD COLSPAN=5>Park, K.S., M.S. Jeong, J.H. Kim, and S.B. Jang. (2005).  Overexpression, purification, and characterization of PDZ domain proteins NHERF and E3KARP in <i>Escherichia coli</i>.  Protein Expr Purif 40: 197-202.<BR><HR></TD></TR><TR><TD COLSPAN=5>Philley, J.V., A. Kannan, and S. Dasgupta. (2016).  MDA-9/Syntenin Control.  J Cell Physiol 231: 545-550.<BR><HR></TD></TR><TR><TD COLSPAN=5>Ravi, A.S., M. Zeng, X. Chen, G. Sandoval, J. Diaz-Alonso, M. Zhang, and R.A. Nicoll. (2022).  Long-term potentiation reconstituted with an artificial TARP/PSD-95 complex.  Cell Rep 41: 111483.<BR><HR></TD></TR><TR><TD COLSPAN=5>Rogelj, B., J.C. Mitchell, C.C. Miller, and D.M. McLoughlin. (2006).  The X11/Mint family of adaptor proteins.  Brain Res Rev 52: 305-315.<BR><HR></TD></TR><TR><TD COLSPAN=5>Ruan, Y.C., Y. Wang, N. Da Silva, B. Kim, R.Y. Diao, E. Hill, D. Brown, H.C. Chan, and S. Breton. (2014).  CFTR interacts with ZO-1 to regulate tight junction assembly and epithelial differentiation through the ZONAB pathway.  J Cell Sci 127: 4396-4408.<BR><HR></TD></TR><TR><TD COLSPAN=5>Setoguchi, K., H. Otera, and K. Mihara. (2006).  Cytosolic factor- and TOM-independent import of C-tail-anchored mitochondrial outer membrane proteins.  EMBO. J. 25: 5635-5647.<BR><HR></TD></TR><TR><TD COLSPAN=5>Sun, N., Y.J. Qin, C. Xu, T. Xia, Z.W. Du, L.P. Zheng, A.A. Li, F. Meng, Y. Zhang, J. Zhang, X. Liu, T.Y. Li, D.Y. Zhu, and Q.G. Zhou. (2022).  Design of fast-onset antidepressant by dissociating SERT from nNOS in the DRN.  Science 378: 390-398.<BR><HR></TD></TR><TR><TD COLSPAN=5>Tan, H.L., S.L. Chiu, Q. Zhu, and R.L. Huganir. (2020).  GRIP1 regulates synaptic plasticity and learning and memory.  Proc. Natl. Acad. Sci. USA 117: 25085-25091.<BR><HR></TD></TR><TR><TD COLSPAN=5>Walsh, D.R., T.D. Nolin, and P.A. Friedman. (2015).  Drug Transporters and Na<sup>+</sup>/H<sup>+</sup> Exchange Regulatory Factor PSD-95/<i>Drosophila</i> Discs Large/ZO-1 Proteins.  Pharmacol Rev 67: 656-680.<BR><HR></TD></TR><TR><TD COLSPAN=5>Wang, P., Z. Ye, and D.K. Banfield. (2020).  A novel mechanism for the retention of Golgi membrane proteins mediated by the Bre5p/Ubp3p deubiquitinase complex.  Mol. Biol. Cell 31: 2139-2155.<BR><HR></TD></TR><TR><TD COLSPAN=5>Xavier, R., S. Rabizadeh, K. Ishiguro, N. Andre, J.B. Ortiz, H. Wachtel, D.G. Morris, M. Lopez-Ilasaca, A.C. Shaw, W. Swat, and B. Seed. (2004).  Discs large (Dlg1) complexes in lymphocyte activation.  J. Cell Biol. 166: 173-178.<BR><HR></TD></TR><TR><TD COLSPAN=5>Yang, J., R. Sarker, V. Singh, P. Sarker, J. Yin, T.E. Chen, R. Chaerkady, X. Li, C.M. Tse, and M. Donowitz. (2015).  The NHERF2 sequence adjacent and upstream of the ERM-binding domain affects NHERF2-ezrin binding and dexamethasone stimulated NHE3 activity.  Biochem. J. 470: 77-90.<BR><HR></TD></TR><TR><TD COLSPAN=5>Yang, J., V. Singh, B. Cha, T.E. Chen, R. Sarker, R. Murtazina, S. Jin, N.C. Zachos, G.H. Patterson, C.M. Tse, O. Kovbasnjuk, X. Li, and M. Donowitz. (2013).  NHERF2 protein mobility rate is determined by a unique C-terminal domain that is also necessary for its regulation of NHE3 protein in OK cells.  J. Biol. Chem. 288: 16960-16974.<BR><HR></TD></TR><TR><TD COLSPAN=5>Yun, J.H., S.W. Park, K.J. Kim, J.S. Bae, E.H. Lee, S.H. Paek, S.U. Kim, S. Ye, J.H. Kim, and C.H. Cho. (2017).  Endothelial STAT3 Activation Increases Vascular Leakage Through Downregulating Tight Junction Proteins: Implications for Diabetic Retinopathy.  J Cell Physiol 232: 1123-1134.<BR><HR></TD></TR><TR><TD COLSPAN=5>Zeng, M., J. Díaz-Alonso, F. Ye, X. Chen, J. Xu, Z. Ji, R.A. Nicoll, and M. Zhang. (2019).  Phase Separation-Mediated TARP/MAGUK Complex Condensation and AMPA Receptor Synaptic Transmission.  Neuron. 104: 529-543.e6.<BR><HR></TD></TR><TR><TD COLSPAN=5>Zhang, W., Z. Zhang, Y. Zhang, and A.P. Naren. (2017).  CFTR-NHERF2-LPA₂ Complex in the Airway and Gut Epithelia.  Int J Mol Sci 18:.<BR><HR></TD></TR><TR><TD COLSPAN=5>Zou, S., J.D. Pita-Almenar, and A. Eskin. (2011).  Regulation of glutamate transporter GLT-1 by MAGI-1.  J Neurochem 117: 833-840.<BR><HR></TD></TR><TR><TD COLSPAN=5><B>Examples:</B><P></TD></TR><TR bgcolor="#99ccff"><TD>TC#</TD><TD>Name</TD><TD>Organismal Type</TD><TD>Example</TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.24.1.1"></A><A HREF="tcprotein.php?substrate=8.A.24.1.1&tcname=">8.A.24.1.1</a></TD><TD><b><font color=#3333CC><p>NHERF1; NHERF-1; EBP50; SlcA3R1.&nbsp; Na<sup>+</sup>/H<sup>+</sup> exchanger regulatory factor (NHERF) proteins are a family of PSD-95/Discs-large/ZO-1
(PDZ)-scaffolding proteins, three of which (NHERFs 1-3) are localized to the brush border in kidney
and intestinal epithelial cells. All NHERF proteins are involved in anchoring membrane proteins that
contain PDZ recognition motifs to form multiprotein signaling complexes.&nbsp; These NHERF proteins exhibit differential mobility in membranes (<a class="reflink" href="result.php?tc=8.A.24#ref10225">Yang <em>et al.</em> 2013</a>).&nbsp; Sites involved in binding to NPT2A (TC# 2.A.58.1.1) have been identified (<span id="ref34544160.26070212" class="cite">Mamonova <em>et al.</em> 2015</span>).&nbsp; Dynamic structures of the full-length NHERF1 influences signaling complex assembly (<span id="ref34549829.31171716" class="cite">Bhattacharya <em>et al.</em> 2019</span>). Thus, modulation of the intrinsic flexibility of NHERF1 by disease-associated point mutations alters assembly.</p></TD><TD><b><font color=#3333CC><p>Animals</p></TD><TD><b><font color=#3333CC><p>SLC9A3R1 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.24.1.10"></A><A HREF="tcprotein.php?substrate=8.A.24.1.10&tcname=">8.A.24.1.10</a></TD><TD><b><font color=#3333CC><p>Golgi-associated PDZ and coiled-coil motif-containing protein, PIST or GOPC, of 462 aas and 1 possible N-terminal TMS.&nbsp; The protein <span>plays a role in intracellular protein trafficking 
and degradation, but also regulates CFTR chloride currents and acid-induced 
ASIC3 currents by modulating cell surface expression of both channels (<span id="ref34551215.14570915" class="cite">Cheng <em>et al.</em> 2004</span>; <span id="ref34551216.15358775" class="cite">He <em>et al.</em> 2004</span>). It also regulates the intracellular trafficking of the ADR1B receptor and plays a role in autophagy. Overexpression results in CFTR 
intracellular retention and degradation in the lysosomes (<span id="ref34551214.11707463" class="cite">Cheng <em>et al.</em> 2002</span>). </span>The retention of Golgi membrane proteins can also be mediated by the Bre5p/Ubp3p deubiquitinase complex (<span id="ref34553379.32673164" class="cite">Wang <em>et al.</em> 2020</span>).</p>
<p>&nbsp;</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>PIST of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.24.1.11"></A><A HREF="tcprotein.php?substrate=8.A.24.1.11&tcname=">8.A.24.1.11</a></TD><TD><b><font color=#3333CC><p><a></a></p>
<p><!-- test--></p>
<p><a id="9.B.106.3.2"></a></p>
<p>CASK ser/thr protein kinase of 898 aas and 0 probable TMSs; it activates Eag (1.A.1.20.6).</p></TD><TD><b><font color=#3333CC><p>Animals</p></TD><TD><b><font color=#3333CC><p>CASK of <em>Drosophila melanogaster</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.24.1.12"></A><A HREF="tcprotein.php?substrate=8.A.24.1.12&tcname=">8.A.24.1.12</a></TD><TD><b><font color=#3333CC><p>Glutamate receptor-interacting protein 1, GRIP1, of 1128 aas and possibly one C-terminal TMS. It m<span>ay play a role as a localized scaffold for the 
assembly of multiprotein signaling complexes and as a mediator of the 
trafficking of its binding partners at specific subcellular location in 
neurons (<span id="ref34552246.10197531" class="cite">Br&uuml;ckner <em>et al.</em> 1999</span>).
 Through complex formation with NSG1, GRIA2 and STX12, it controls the 
intracellular fate of AMPAR and the endosomal sorting of the GRIA2 
subunit toward recycling and membrane targeting. It regulates the surface expression and synaptic stabilization of AMPARs by direct interaction with several members of the AMPAR family, and thereby&nbsp; </span>regulates synaptic plasticity in learning and memory<span> (<span id="ref34552247.32948689" class="cite">Tan <em>et al.</em> 2020</span>).<br /></span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>GRIP1 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.24.1.13"></A><A HREF="tcprotein.php?substrate=8.A.24.1.13&tcname=">8.A.24.1.13</a></TD><TD><b><font color=#3333CC><p>Tight Junction Protein ZO3, TJPZO3, of 919 aas and 1 moderatedly hudrophobic potential TMS near the N-terminus of the protein. Its function may overlap with that of TJPZ1 (TC# 8.A.24.1.9). With TJP2 and TJP3, it participates in the junctional retention and stability of the transcription factor DBPA. TJP1, TJP2, and TJP3 are closely related scaffolding proteins that link 
tight junction (TJ) transmembrane proteins such as claudins, junctional 
adhesion molecules, and occludin to the actin cytoskeleton (<span id="ref34555441.7798316" class="cite">Furuse <em>et al.</em> 1994</span>, <span id="ref34555442.9792688" class="cite">Fanning <em>et al.</em> 1998</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>TJPZO3 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.24.1.2"></A><A HREF="tcprotein.php?substrate=8.A.24.1.2&tcname=">8.A.24.1.2</a></TD><TD><b><font color=#3333CC><p>Solute carrier family 9, subfamily A (NHE3 cation proton antiporter 3 regulatory factor), member 3 regulator 2, SLC9A3R2, SNX27 (sorting nexin 27) or NHERF2 of 337 aas.&nbsp; It binds erzin and affects dexamethasone stimulated NHE3 activity (<span id="ref34544693.26251448" class="cite">Yang <em>et al.</em> 2015</span>).&nbsp; It also regulates several other transporters including CFTR (TC# 3.A.1.202.1) (<span id="ref34548890.28869532" class="cite">Zhang <em>et al.</em> 2017</span>). SNX27 directly interacts with DRA (SLC26A3; TC# 2.A.53.2.18) in early endosomes and mediates its direct recycling to facilitate high activity in lipid rafts in the apical plasma membrane (<span id="ref34551300.32116023" class="cite">Bannert <em>et al.</em> 2020</span>).</p></TD><TD><b><font color=#3333CC><p>Animals</p></TD><TD><b><font color=#3333CC><p>SLC9A3R2 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.24.1.3"></A><A HREF="tcprotein.php?substrate=8.A.24.1.3&tcname=">8.A.24.1.3</a></TD><TD><b><font color=#3333CC><p>Na<sup>+</sup>/H<sup>+</sup> exchange regulatory factor (NHERF) or discs large homologue 4, PSD-95, PSD95, Dig4, Digh4 of 724 aas and 0 TMSs. Acts to stabilize and organize membrane targeting of multiple
transmembrane proteins, including many clinically relevant drug transporters. These PDZ proteins are
normally abundant at apical membranes, where they tether membrane-delimited transporters. NHERF
expression is particularly high at the apical membrane in polarized tissue such as intestinal,
hepatic, and renal epithelial tissues (<span>Walsh <em>et al.</em> 2015</span>). DLG4 or PSD95 <span>interacts with the cytoplasmic tail of NMDA
 receptor subunits and shaker-type potassium channels and is required for 
synaptic plasticity associated with NMDA receptor signaling. 
Overexpression or depletion of DLG4 changes the ratio of excitatory to 
inhibitory synapses in hippocampal neurons. Moreover, DLG4 may reduce the amplitude of 
ASIC3 acid-evoked currents by retaining the channel intracellularly. It also
 regulates the intracellular trafficking of ADR1B and controls 
AMPA-type glutamate receptor (AMPAR) immobilization at postsynaptic 
density, keeping the channels in an activated state in the presence of 
glutamate and preventing synaptic depression.&nbsp; This involves palmitoylation (<span>Jeyifous <em>et al.</em> 2016</span>). </span><span>Stargazin in complex with PSD-95 or PSD-95-assembled postsynaptic 
complexes forms highly concentrated and dynamic condensates via phase 
separation, reminiscent of stargazin/PSD-95-mediated AMPAR synaptic 
clustering and trapping (<span id="ref34551181.31492534" class="cite">Zeng <em>et al.</em> 2019</span>). </span>AMPA receptor (AMPAR) trafficking in long-term potentiation (LTP) of excitatory synaptic transmission is well established. PSD-95 captures AMPARs via an interaction with the AMPAR auxiliary subunits-transmembrane AMPAR regulatory proteins (TARPs). The TARP/PSD-95 complex is an essential interaction underlying AMPAR trafficking and LTP (<span id="ref34555607.36223737" class="cite">Ravi <em>et al.</em> 2022</span>).</p></TD><TD><b><font color=#3333CC><p>Animals</p></TD><TD><b><font color=#3333CC><p>PSD95 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.24.1.4"></A><A HREF="tcprotein.php?substrate=8.A.24.1.4&tcname=">8.A.24.1.4</a></TD><TD><b><font color=#3333CC><p>Group II metabotropic glutamate receptor, mGluR2/3, interacting protein, Grip2, of 1043 aas.&nbsp; <span>May play a role as a localized scaffold for
 the assembly of multiprotein signaling complexes and as mediator of the
 trafficking of its binding partners at specific subcellular locations in
 neurons. </span>In mutant mice, the mGluR2/3 agonist, LY379268, restores excitatory and inhibitory defects with similar
efficiency as olanzapine in a two-hit schizophrenia mouse model (<span id="ref34546279.26861891" class="cite">Engel <em>et al.</em> 2016</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Grip2 of <em>Rattus norvegicus </em>(Rat)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.24.1.5"></A><A HREF="tcprotein.php?substrate=8.A.24.1.5&tcname=">8.A.24.1.5</a></TD><TD><b><font color=#3333CC><p>Synaptojanin-2 binding protein, Omp25, of 145 aas with a C-terminal TMS (C-tail-anchored mitochondrial outer membrane protein) (<span id="ref34546676.17110923" class="cite">Setoguchi <em>et al.</em> 2006</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Omp25 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.24.1.6"></A><A HREF="tcprotein.php?substrate=8.A.24.1.6&tcname=">8.A.24.1.6</a></TD><TD><b><font color=#3333CC><p>MAGI-2 or MAGI2 of 1455 aas. S<span>caffold protein at synaptic junctions, assembling neurotransmitter receptors and cell adhesion proteins (<span id="ref34547202.10760291" class="cite">Wu <em>et al.</em> 2000</span>). It is </span>a multi-PDZ domain scaffolding protein that interacts with several different ligands in brain, including hyperpolarization-activated cation channels, beta1-adrenergic receptors, and NMDA receptors.&nbsp; MAGI-2 is a strong candidate for linking TARP/AMPA receptor complexes to a wide range of other postsynaptic proteins and pathways (<span id="ref34547203.16870733" class="cite">Deng <em>et al.</em> 2006</span>).</p>
<p>&nbsp;</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>MAGI2 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.24.1.7"></A><A HREF="tcprotein.php?substrate=8.A.24.1.7&tcname=">8.A.24.1.7</a></TD><TD><b><font color=#3333CC><p>Disc large homolog, 1DLG1 or SAP97, of 904 aas and 0 TMSs. <span>Essential multidomain scaffolding protein 
required for normal development and lymphocyte activation (<span id=""ref34547485.15263016"" class=""cite"">Xavier <em>et al.</em> 2004</span>). Recruits channels, 
receptors and signaling molecules to discrete plasma membrane domains in
 polarized cells. May play a role in adherens junction assembly, signal 
transduction, cell proliferation and synaptogenesis. Regulates the excitability of cardiac myocytes by modulating
 the functional expression of Kv4 and Kv1.5 channels (<span id=""ref34547484.19213956"" class=""cite"">El-Haou <em>et al.</em> 2009</span>).<br /></span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>DLG1 of<em> Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.24.1.8"></A><A HREF="tcprotein.php?substrate=8.A.24.1.8&tcname=">8.A.24.1.8</a></TD><TD><b><font color=#3333CC><p>Stardust, Sdt, of 879 aas and 1 N-terminal TMS.&nbsp; Sdt is a scaffolding protein that stabilizes the transmembrane protein, Crumbs (TC# 9.B.87.1.11), a conserved regulator of apical-basal epithelial polarity (<span id="ref34547508.28416478" class="cite">Das and Knust 2017</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Sdt of <em>Drosophila melanogaster </em>(Fruit fly)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.24.1.9"></A><A HREF="tcprotein.php?substrate=8.A.24.1.9&tcname=">8.A.24.1.9</a></TD><TD><b><font color=#3333CC><p>Zonula occludens-1 (ZO-1) (tight junction protein, TJP1) of 1748 aas. Regulates intestinal barrier function (<span>Nicolodi and Sicuteri 1996</span>), gap and tight junctions (<span>Giepmans 2006</span>; <span>Yun <em>et al.</em> 2017</span>), the organic cation/carnitine transporter, OCTN2 (<span>Jurkiewicz <em>et al.</em> 2017</span>), and CFTR (<span>Ruan <em>et al.</em> 2014</span>) among others. It may have 4 C-terminal TMSs. Wine-processed Chuanxiong Rhizoma enhances efficacy of aumolertinib against EGFR mutant non-small cell lung cancer xenografts in nude mouse brain (<span id="ref34556387.37087581" class="cite">Niu <em>et al.</em> 2023</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>ZO-1 of<em> Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR><TD COLSPAN=5><B>Examples:</B><P></TD></TR><TR bgcolor="#99ccff"><TD>TC#</TD><TD>Name</TD><TD>Organismal Type</TD><TD>Example</TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.24.2.1"></A><A HREF="tcprotein.php?substrate=8.A.24.2.1&tcname=">8.A.24.2.1</a></TD><TD><b><font color=#3333CC><p>Syntenin-1, SDCBP, of 298 aas and 1 C-terminal TMS, is also called syndecan binding protein-1, scaffold protein Pbp1, and melanoma differentiation-associated protein 9 (MDA-9) (<span id="ref34546772.28546458" class="cite">Mitsou <em>et al.</em> 2017</span>). <span>Multifunctional adapter protein involved in
 a diverse array of functions including trafficking of transmembrane 
proteins, neuro and immunomodulation, exosome biogenesis, and 
tumorigenesis (<span id="ref34546773.26291527" class="cite">Philley <em>et al.</em> 2016</span>). </span>Syndecans can regulate stretch-activated ion channels. The structure and function of the syndecans have been reviewed (<span id="ref34546772.28546458" class="cite">Mitsou <em>et al.</em> 2017</span>). ESCRT-to-membrane coupling via ALIX/syntenin/syndecan-4 is required for completion of cytokinesis (<span id="ref34551887.32321914" class="cite">Addi <em>et al.</em> 2020</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Syntenin-1 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.24.2.2"></A><A HREF="tcprotein.php?substrate=8.A.24.2.2&tcname=">8.A.24.2.2</a></TD><TD><b><font color=#3333CC><p>Amyloid-beta A4 precursor protein-binding family A member 1, Mint1 or APBA1, of 837 aas and 3 or more C-terminal TMSs. Mint1 <span>functions in synaptic vesicle exocytosis by 
binding to Munc18-1, an essential component of the synaptic vesicle 
exocytotic machinery. It may also modulate processing of the amyloid-beta 
precursor protein (APP) and hence formation of APP-beta.&nbsp; </span>Munc18 bridges the few syntaxin molecules residing on granules to the syntaxin cluster on the plasma membrane, suggesting that the number of syntaxins on vesicles determines docking and fusion probability (<span id="ref34549089.29317735" class="cite">Borisovska 2018</span>).</p>
<p>&nbsp;</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Mint1 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.24.2.3"></A><A HREF="tcprotein.php?substrate=8.A.24.2.3&tcname=">8.A.24.2.3</a></TD><TD><b><font color=#3333CC><p>Amyloid-beta A4 precursor protein-binding family A member 2, APBA2 or Mint2, of 749 aas and 3 or more C-terminal TMSs. Mint1 and 2, of the X11 protein family, are multidomain proteins composed of a conserved 
PTB domain and two C-terminal PDZ domains. They are involved in 
formation of multiprotein complexes, and two of the family members, 
X11alpha and X11beta, are expressed primarily in neurons. Through interactions 
with other neuronal proteins, they may modulate processing of APP and accumulation of 
Abeta (<span id="ref34549091.16764936" class="cite">Rogelj <em>et al.</em> 2006</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>Mint2 of<em> Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.24.2.4"></A><A HREF="tcprotein.php?substrate=8.A.24.2.4&tcname=">8.A.24.2.4</a></TD><TD><b><font color=#3333CC><p>Brain nitric oxide synthase, NOS1, of 1434 aas and probably 0 TMSs. It produces nitric oxide (NO) which is a messenger molecule with diverse 
functions throughout the body. In the brain and peripheral nervous 
system, NO displays many properties of a neurotransmitter. It probably has 
nitrosylase activity and mediates cysteine S-nitrosylation of 
cytoplasmic target proteins such SRR. Major depressive disorder (MDD) is one of the most common mental 
disorders.&nbsp;<span id="ref34555533.36302033" class="cite">Sun <em>et al.</em> 2022</span> designed a fast-onset antidepressant that works by 
disrupting the interaction between the serotonin transporter (SERT; TC# 2.A.22.1.1) and 
neuronal nitric oxide synthase (nNOS) in the dorsal raphe nucleus (DRN).
 Chronic unpredictable mild stress (CMS) selectively increases the 
SERT-nNOS complex in the DRN in mice. Augmentation of SERT-nNOS 
interactions in the DRN causes a depression-like phenotype and accounts
 for CMS-induced depressive behaviors. Disrupting the SERT-nNOS 
interaction produces a fast-onset antidepressant effect by enhancing 
serotonin signaling in forebrain circuits. A
small-molecule compound, ZZL-7 elicits an antidepressant effect 2
 hours after treatment without undesirable side effects. This compound, 
or analogous reagents, may serve as a new, rapidly acting treatment for 
MDD (<span id="ref34555533.36302033" class="cite">Sun <em>et al.</em> 2022</span>).</p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>NOS1 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR><TD COLSPAN=5><B>Examples:</B><P></TD></TR><TR bgcolor="#99ccff"><TD>TC#</TD><TD>Name</TD><TD>Organismal Type</TD><TD>Example</TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="8.A.24.3.1"></A><A HREF="tcprotein.php?substrate=8.A.24.3.1&tcname=">8.A.24.3.1</a></TD><TD><b><font color=#3333CC><p>PRKCA-binding protein, PICK1, of 229 aas and possibly one TMS near the N-terminus. <span>It is a probable adapter protein that binds to and organizes
 the subcellular localization of a variety of membrane proteins 
containing PDZ recognition sequences. It is involved in the clustering of 
various receptors, possibly by acting at the receptor internalization 
level. It plays a role in synaptic plasticity by regulating the trafficking
 and internalization of AMPA receptors and may be regulated upon PRKCA 
activation. It may regulate ASIC1/ASIC3 channels.</span></p></TD><TD><b><font color=#3333CC></TD><TD><b><font color=#3333CC><p>PICK1 of <em>Homo sapiens</em></p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR></TABLE>
</CENTER>
</BODY>
</HTML>
